142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

309251
Pharmaceutical Opioid Abuse among Suburban Drug Injectors

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014

Robert Heimer, Ph D , Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT
Lauretta E. Grau, Ph D , Department of Epidemiology and Public Health, Yale University, New Haven, CT
Russell Barbour, Ph.D. , Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT
Opioid addiction often begins with abuse of pharmaceutical opioids (PO), but little is known about transitions to addiction, heroin use, and drug injection among PO abusers.  We recruited 462 injectors who reside in suburban communities in southwestern Connecticut and collected data on their past and present drug use, access to drug treatment and somatic disease prevention services, and experiences with the criminal justice system.  Among these individuals, all with a history of heroin injection, 376 had ever used POs, 153 had used and 63 had injected PO in the month prior to interview.  A history of PO use was associated with a greater likelihood of having been in drug treatment, but also a greater likelihood of have been denied treatment or having treatment prematurely interrupted.  PO use was also associated with an increased likelihood of having been arrested.  There was no difference in use of syringe exchange services that are located in the cities that the suburbs surround.  Current PO use was not associated with any of these treatment or criminal justice variables but was associated with currently experiencing chronic non-cancer pain that interferes with daily activities.  Regardless of PO use, 80% of those with chronic pain reported abusing opioids prior to the onset of pain.  These findings suggest that while the drug abuse trajectories of people have used PO in the past may differ from those who have not, current use of PO is only differential for those reporting chronic pain.

Learning Areas:

Chronic disease management and prevention
Planning of health education strategies, interventions, and programs

Learning Objectives:
Identify pharmaceutical opioid abuse patterns among residents of suburbs of southwestern Connecticut who inject drugs. Compare the exposure of injectors who use pharmaceutical opioids to substance abuse treatment and the criminal justice system to those who do not use pharmaceutical opioids. Assess the timing of the initiation of pharmaceutical and heroin abuse.

Keyword(s): Drug Abuse, Treatment Patterns

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been the principal or co-principal of multiple federally funded grants focusing on the epidemiology of drug abuse and co-occurring somatic and mental health problems. Among my scientific interests has been the development of strategies for expanding drug users' access to health services.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.